Cytogen Inc (217330) — Financial Flexibility Index
Cytogen Inc (217330) has a Financial Flexibility Index of -0.08x as of December 2025. Free cash flow of ₩-2.08 Billion (operating CF ₩-2.13 Billion minus capex ₩49.52 Million) represents 0% of total liabilities (₩26.25 Billion). Check 217330 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cytogen Inc Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Cytogen Inc across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Cytogen Inc.
Annual Financial Flexibility Index for Cytogen Inc (2014–2025)
Year-by-year free cash flow to debt coverage for Cytogen Inc. Explore Cytogen Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.19x | ₩-4.92 Billion | ₩-6.95 Billion | ₩26.25 Billion | ▲ +46.8% |
| 2024 | -0.35x | ₩-8.41 Billion | ₩-9.53 Billion | ₩23.89 Billion | ▼ -49.3% |
| 2023 | -0.24x | ₩-4.97 Billion | ₩-7.59 Billion | ₩21.09 Billion | ▼ -48.8% |
| 2022 | -0.16x | ₩-5.63 Billion | ₩-6.38 Billion | ₩35.56 Billion | ▼ -59.3% |
| 2021 | -0.10x | ₩-3.23 Billion | ₩-5.23 Billion | ₩32.52 Billion | ▲ +76.4% |
| 2020 | -0.42x | ₩-4.20 Billion | ₩-4.47 Billion | ₩9.97 Billion | ▲ +73.1% |
| 2019 | -1.56x | ₩-2.81 Billion | ₩-3.37 Billion | ₩1.80 Billion | ▲ +23.7% |
| 2018 | -2.05x | ₩-1.46 Billion | ₩-2.77 Billion | ₩711.51 Million | ▼ -4.1% |
| 2017 | -1.97x | ₩-1.86 Billion | ₩-2.18 Billion | ₩947.50 Million | ▼ -347.6% |
| 2016 | -0.44x | ₩-2.02 Billion | ₩-2.36 Billion | ₩4.59 Billion | ▲ +58.1% |
| 2015 | -1.05x | ₩-1.67 Billion | ₩-2.03 Billion | ₩1.60 Billion | ▼ -250.0% |
| 2014 | -0.30x | ₩-470.57 Million | ₩-1.03 Billion | ₩1.57 Billion | — |